Daily Alternating Deferasirox and Deferiprone Therapy Successfully Controls Iron Accumulation in Untreatable Transfusion Dependent Thalassemia Patients
American Journal of Hematology - United States
doi 10.1002/ajh.25222
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 14, 2018
Authors
Publisher
Wiley